Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Lleida (108)

2023

  1. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

    European Archives of Psychiatry and Clinical Neuroscience

  2. Breathing cessation events that compose the apnea-hypopnea index are distinctively associated with the adverse outcomes in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 123

  3. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  4. Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738

  5. Editorial: The underlying relationship between sleep and neurodegenerative diseases

    Frontiers in Neuroscience

  6. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  7. Genetic Associations between Modifiable Risk Factors and Alzheimer Disease

    JAMA Network Open, Vol. 6, Núm. 5

  8. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science, Vol. 10, Núm. 32

  9. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

  10. Lithium management of periodic mood fluctuations in behavioural frontotemporal dementia: a case report

    Frontiers in Psychiatry, Vol. 14

  11. Live Cell Adhesion, Migration, and Invasion Assays

    Methods in Molecular Biology (Humana Press Inc.), pp. 313-329

  12. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  13. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling

    Biomedicine and Pharmacotherapy, Vol. 168